By
From * Istituto I Clinica Medica, Università di Roma "La Sapienza", I-00161 Rome, Italy; and Roche Milano Ricerche, I-20132 Milan, Italy
Both T cell tolerance and productive T cell responses
require the interaction of the TCR with specific
MHC-peptide ligands, triggering a cascade of signals that
ultimately can lead to either proliferation or cell death (1-
3). These two opposing processes, which can occur during
both peripheral T cell activation and/or positive/negative
selection of T cells in the thymus, seem to be tuned by two
different mechanisms: either by the strength of avidity/affinity of the TCR for their ligands, or by the differential changes in the conformation or orientation of the TCR after its ligation on the MHC-peptide complexes (4, 5). Recently, the outcomes of T cell activation in periphery or of
thymic selection have been related to the agonist or antagonist activity of MHC peptide ligands for the TCR; the
agonist ligands, having high affinity for the TCR (slow dissociation), would promote deletion in the thymus and full
activation in the periphery; the antagonist ligands, having
low affinity for the TCR (rapid dissociation), would have
the opposite effects (6). Analysis of the intracellular events
in T cells in response to antagonist/partial agonist ligands reported distinct patterns of A report in this issue of The Journal of Experimental Medicine strongly supports the idea that molecular mimicry
could account for the activation and clonal expansion of
autoreactive T cells (17). Previous studies combining single
amino acid substitution analysis at TCR contact residues of
a self peptide, together with the knowledge that amino acid
side chains required for binding to MHC are degenerate
(18), led to the identification of T cell stimulatory ligands
derived from microbial proteins (19). Notably, the identified epitopes did not share sequence homologies with the
autoantigen in positions other than TCR. This type of approach is, however, impaired by the large number of individual peptides necessary to define a single T cell epitope.
The paper by Hemmer et al. describes the use of completely random combinatorial peptide libraries to identify
multiple cross-reactive ligands for an autoreactive T cell
clone specific for peptide 86-96 of the myelin basic protein (MBP). The combinatorial peptide library approach that
has recently been used to define the structural basis for
MHC class II-restricted peptide presentation (20) has emerged
as an extremely powerful way to determine which amino
acid sequence interacts with a particular protein. In the
Hemmer et al. study (17), the authors have analyzed the response of the MBP-specific clone to 220 11-mer peptide
sublibraries. Based on the results obtained with the peptide
libraries for each amino acid position of the peptide sequence, novel peptides were found that induced proliferative response at much lower concentrations than original
MBP peptide. The analysis of these sequences by protein
database search led to the identification of cross-reactive peptides derived from self and microbial proteins; some of
them were more potent agonists than the MBP peptide for
T cell activation. From these data, the authors conclude
that for at least some autoreactive T cells, antigen recognition is highly degenerate. The elegant work by Hemmer et
al. is reminiscent of results of Nanda et al. (21), suggesting
that some TCR, as well as polyspecific Ig, could have a
multisite structure capable of being stimulated by a large
panel of peptides associated with a given MHC molecule. Altogether, these evidences could shed a new light on old
data demonstrating that virtually all antigen-specific T cells
are degenerate since they are capable of recognizing different allelic forms of MHC-peptide complexes (22). The recently solved three-dimensional structure of a human TCR-
MHC-peptide complex provides a structural basis for the
limited specificity of the TCR (23, 24). The peptide is
bound very deeply in the MHC molecule, thus providing only a few atoms of peptide residues for the contact with
the TCR (24).
An interesting point discussed by Hemmer et al. (17) is
that since the MBP-specific T cell clone proliferates to ~2 × 1011 different peptides resulting in assay concentrations of 5 × 10 A number of studies have demonstrated that although
the recognition by the TCR is rather flexible in that more
than one type of peptide can induce a response, the quality
of the T cell response evoked by such so-called altered
peptide ligands (APLs) can be very different (27). Hemmer
et al. (17) only consider those peptides with agonist function resulting in cross-reactive responses by the MBP(8696)-specific T cell clone. It is reasonable to assume that the
response by the same clone could be dramatically different in response to APLs, which should be equally represented
either in peptide libraries used by the Martin's group (17),
or among peptides presented by APCs in vivo. Some of the
APLs could induce different stimulatory functions, whereas
others could switch off the T cell activation and thus influence the establishment of positive/negative selection in the
thymus or of clonal activation, partial activation, or anergy
in periphery.
In conclusion, the findings reported by Hemmer et al., as
well as that by other laboratories (17, 19), have important implications for the pathogenesis of autoimmune disease
because they establish an important link between immune
responses to infectious agents and autoimmunity. With respect to the mechanisms by which the molecular mimicry
at the T cell level could lead to disease, the following scenario could be envisaged. Although the number of self
peptides presented by living cells is much more restricted than that shown with artificial peptide repertoires, negative or positive selection in the thymus for those T cells having
a high degree of TCR degeneracy may be determined by
the quality of the stimulation which results in the recognition of the different ligands presented by thymic APCs (27,
28). Thus, in addition to known parameters, such as the affinity/avidity of TCR for MHC-peptide complexes, the
stability of the MHC-peptide complexes and the kinetics
of TCR-MHC-peptide interaction, the degeneracy of antigen recognition by TCR seems to play a major role in influencing T cell selection. In particular, thymocytes engaging multiple agonist ligands will undergo negative selection
(low off-rate interaction). In contrast, T cells triggered by a
larger amount of different APLs, which could overwhelm
the function of agonist peptides simultaneously present on
APCs, will be positively selected, and therefore, will become part of the peripheral T cell pool (high off-rate interaction). Hemmer et al. suggest that these cells presumably
would remain harmless in the periphery in case they encounter the same self peptides which positively selected the
T cells in the thymus (17). It is tempting to hypothesize
that if a peripheral T cell is fully activated by a given microbial epitope, the pool of cross-reactive self peptides, if acting as APLs, could switch off T cell activation. This mechanism could be advantageous for controlling autoimmunity, but disadvantageous for clearing those pathogens which
have not been promptly eliminated during the early phases
of the infections. Alternatively, a more adverse picture
could be depicted: the T cell, activated by a microbial peptide, could also cross-react with multiple agonist self epitopes
which, being cryptic, have not induced negative selection
in the thymus, thus leading to priming and the establishment of autoimmune processes. This, however, should be a
remote possibility in view of the different "protective" mechanisms that can take place. (a) Self epitopes are generally sequestered in privileged organs and are thus inaccessible to the immune system, or are cryptic because they are not generated or generated in insufficient amounts during constitutive
processing by APCs. This means that they have to be unveiled, for instance, by inflammatory processes after viral infections to be efficiently processed and presented by professional APCs (14). (b) Cryptic epitopes may be presented by
nonprofessional APCs, such as resting B cells or epithelial
cells, which could tolerize the autoreactive T cells (29). (c)
The cross-reactive self epitopes, once unveiled, will not necessarily behave as agonists, but may act either as an antagonist
or as a partial agonist for TCR, leading to either death, anergy, or a change in the T cell function (27). These mechanisms could account for the limited occurrence of autoimmune phenomena despite the TCR degeneracy.
chain phosphorylation followed by a failure to activate the ZAP-70 kinase (7, 8).
Costimulatory molecules were also shown to play a crucial
role in the signaling events, e.g., interactions between B7.1
or B7.2 and CD28, or CD40 and CD40L can provide costimulatory signals for T cell priming in periphery or for
deletion during intrathymic T cell development (9, 10). In
this context, several experimental models suggest that tolerance of self-reactive T cells can only be established to those
self determinants that are generated in sufficient amounts during processing to be recognized by T cells undergoing
deletion in the thymus or anergy in the periphery (11). Indeed, there is ample evidence that self-reactive T cells escaping from thymic tolerance exist in the peripheral T cell
pool of healthy individuals or experimental animals (12).
This may occur if the self determinants are not expressed in
the thymus, e.g. if they are cryptic, because they are not
generated, or they are generated at subthreshold levels for
acting as T cell epitopes (11, 13, 14). T cells specific for
these epitopes are present in the normal repertoire in ignorance, but might be activated and become dangerous if the cryptic epitopes are made "visible" to the immune system
(13). A critical question is how self epitopes that are
normally cryptic can influence positive selection of specific
T cells in the thymus and can elicit autoreactive T cells in
periphery sustaining pathogenetic responses. Different mechanisms have been proposed, particularly for explaining how
cryptic epitopes can be unveiled on the one hand, and how
ignorant autoreactive T cells can be awakened in periphery
on the other hand (11).
19 g/ml for each single peptide, a concentration far below the concentration of the best hypothetical T cell
epitope, it is plausible to envisage that the library contains a
high number of different ligands that are stimulatory for the
T cell clone. In reality, however, the degeneracy of T cell
recognition may be less frequent than expected. Indeed,
only a few of these sequences will be generated from natural proteins, and even fewer will be generated during antigen processing. Moreover, with regard to the self epitopes
generated and presented by APCs, they seem to be no
more than a few thousand (25, 26). Thus, the possibility
that a degenerated TCR on a given T cell can be triggered
by multiple self epitopes presented on the thymic APCs is
expected to be exceptional.
Address correspondence to Francesco Sinigaglia, Roche Milano Ricerche, Via Olgettina 58, I-20132 Milan, Italy, or Vincenzo Barnaba, Istituto I Clinica Medica, Università oli Roma "La Spienza," I-00161 Rome, Italy.
Received for publication 19 March 1996.
V. Barnaba is supported in part by grants from Fondazione "Andrea Cesalpino" and Associazione Italiana Sclerosi Multipla.1. | Ward, E.S., and A. Qadri. 1997. Biophysical and structural studies of TCRs and ligands: implications for T cell signaling. Curr. Opin. Immunol. 9: 97-106 [Medline]. |
2. | Weiss, A.. 1993. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell. 73: 209-212 [Medline]. |
3. | Janeway, C.A., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76: 275-285 [Medline]. |
4. | Margulies, D.H.. 1996. An affinity for learning. Nature (Lond.). 381: 558-559 [Medline]. |
5. | Janeway, C.A.. 1995. Ligands for the T-cell receptor: hard times for avidity models. Immunol. Today. 16: 223-225 [Medline]. |
6. | Ohashi, P.S.. 1996. T cell selection and autoimmunity: flexibility and tuning. Curr. Opin. Immunol. 8: 808-814 [Medline]. |
7. | Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (Wash. DC). 267: 515-518 [Medline]. |
8. | Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap-70 recruitment in APL-induced T cell anergy. Cell. 79: 913-922 [Medline]. |
9. | Kruisbeek, A.M., and D. Amsen. 1996. Mechanisms underlying T cell tolerance. Curr. Opin. Immunol. 8: 233-244 [Medline]. |
10. | Foy, T.M., D.M. Page, T.J. Waldschmidt, A. Schoneveld, J.D. Laman, S.R. Masters, L. Tygrett, J.A. Ledbetter, A. Aruffo, E. Claassen, et al . 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182: 1377-1388 [Abstract]. |
11. | Sercarz, E.E., P.V. Lehemann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11: 729-766 [Medline]. |
12. | Wekerle, H., M. Bradl, C. Linington, G. Kaab, and K. Kojioma. 1996. The shaping of the brain-specific T lymphocyte repertoire in the thymus. Immunol. Rev. 149: 231-243 [Medline]. |
13. | Lanzavecchia, A.. 1995. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181: 1945-1948 [Medline]. |
14. | Barnaba, V.. 1996. Viruses, hidden self-epitopes and autoimmunity. Immunol. Rev. 152: 47-66 [Medline]. |
15. | Salemi, S., A.P. Caporossi, L. Boffa, M.G. Longobardi, and V. Barnaba. 1995. HIV-gp120 activates autoreactive CD4specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181: 2253-2257 [Abstract]. |
16. | di Marzo Veronese, F., D. Arnott, V. Barnaba, D.J. Loftus, K. Sagaguchi, C.B. Thompson, S. Salemi, C. Mastroianni, A. Sette, J. Shabanowitz et al. 1996. Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects. J. Exp. Med. 183: 2509-2516 [Abstract]. |
17. |
Hemmer, B.,
B.T. Fleckenstein,
M. Vergelli,
G. Jung,
H. McFarland,
R. Martin, and
K.-H. Wiesmuller.
1997.
Identification of high potency microbial and self ligands for a human autoreactive class II restricted T cell clone.
J. Exp. Med.
185:
1651-1659
|
18. | Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR binding peptides. Cell. 74: 197-203 [Medline]. |
19. | Wucherpfenning, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80: 695-705 [Medline]. |
20. | Hammer, J., F. Gallazzi, E. Bono, R.W. Karr, J. Guenot, P. Valsasnini, Z.A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181: 1847-1855 [Abstract]. |
21. | Nanda, N.K., K.K. Arzoo, H.M. Geysen, A. Sette, and E.E. Sercarz. 1995. Recognition of multiple peptide cores by a single T cell receptor. J. Exp. Med. 182: 531-539 [Abstract]. |
22. |
Ashwell, J.D.,
C. Chen, and
R.H. Schwartz.
1986.
High frequency and nonrandom distribution of alloreactivity in T cell
clones selected for recognition of foreign antigen in association with self class II molecules.
J. Immunol.
136:
389-395
|
23. |
Garcia, K.C.,
M. Degano,
R.L. Stanfield,
A. Brunmark,
M.R. Jackson,
P.A. Peterson,
L. Teyton, and
I.A. Wilson.
1996.
An ab T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex.
Science (Wash. DC).
274:
209-219
|
24. | Garboczi, D.N., P. Ghosh, U. Utz, Q.R. Fan, W.E. Biddison, and D.C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (Lond.). 384: 134-141 [Medline]. |
25. | Christinck, E.R., M.A. Luscher, B.H. Barber, and D.B. Williams. 1991. Peptides binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (Lond.). 352: 67-70 [Medline]. |
26. | Marrack, P., L. Ignatowicz, J.W. Kappler, J. Boymelm, and J.H. Freed. 1993. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 178: 2173-2183 [Abstract]. |
27. | Evavold, B.D., J. Sloan-Lancaster, K.J. Wilson, J.B. Rothbard, and P.M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 2: 655-705 [Medline]. |
28. |
Nakano, N.,
R. Rooke,
C. Benoist, and
D. Mathis.
1997.
Positive selection of T cells induced by viral delivery of neopeptides to the thymus.
Science (Wash. DC)
275:
678-683
|
29. | Schwartz, R.H.. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71: 1065-1068 [Medline]. |